Pharmacokinetic interactions between macitentan and a combined oral contraceptive in healthy female subjects.

Trial Profile

Pharmacokinetic interactions between macitentan and a combined oral contraceptive in healthy female subjects.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Sep 2015

At a glance

  • Drugs Macitentan (Primary) ; Ethinylestradiol/norethisterone
  • Indications Pulmonary arterial hypertension
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 23 Sep 2015 New trial record
    • 18 Sep 2015 Results published in the Journal of Clinical Pharmacology.
    • 02 Sep 2015 Results presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top